VNDA
Vanda Pharmaceuticals Inc
5.10$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Vanda Pharmaceuticals Inc (VNDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -109 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.6 | -18 | -52 | -52 | -46 | 169 | -11 | -28 | -45 | -40 | -82 | 12 | -8.1 | -2.0 | 30 | 46 | 52 | 64 | 32 | 13 | -16 | -109 | |
| 0.4 | 0.4 | 0.6 | 0.6 | 0.5 | 1.4 | 1.8 | 2.0 | 2.1 | 1.9 | 2.8 | 14 | 12 | 3.0 | 3.0 | 2.9 | 2.9 | 2.8 | 2.7 | 3.0 | 8.1 | -1.0 | |
| – | – | 6,132 | 20 | 13 | 11 | 5.0 | 5.5 | 4.1 | 4.6 | 5.9 | 8.0 | 8.5 | 10 | 12 | 13 | 13 | 15 | 16 | 14 | 12 | 9.5 | |
| – | – | – | – | – | – | 3.9 | 7.3 | 4.1 | 4.6 | -72 | 8.6 | 9.1 | 11 | 12 | -73 | 21 | 24 | 20 | – | – | – | |
| 0.4 | 0.7 | 5.5 | 3.8 | -8.6 | 192 | -20 | -29 | -26 | -26 | -33 | 29 | -11 | 0.0 | -7.8 | 3.1 | 4.3 | 2.7 | 6.1 | -0.7 | -6.6 | 8.3 | |
| 0.4 | 0.3 | 1.4 | 0.3 | 0.9 | 12 | 0.0 | 0.3 | 2.0 | 0.2 | 8.8 | 2.5 | 1.4 | 1.7 | 25 | 1.0 | 1.8 | 0.6 | 0.7 | 0.4 | 0.5 | 1.0 | |
| -0.4 | -11 | 8.2 | -49 | 43 | -4.7 | -156 | 74 | 46 | -34 | -12 | -27 | -10 | -10 | -110 | -68 | -41 | -77 | 50 | -12 | -17 | 95 | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | -0.2 | 65 | -0.3 | 7.8 | 5.3 | 107 | 6.3 | 5.6 | 3.6 | 0.7 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | -0.2 | -2.0 | |
| 18 | 33 | 53 | 111 | – | 1.6 | 3.8 | 0.0 | 0.0 | 50 | 90 | 4.1 | 7.8 | 5.3 | 107 | 6.3 | 5.6 | 3.6 | 0.7 | 0.6 | -0.2 | -2.9 | |
| 9.1 | 4.8 | 9.9 | 11 | -2.9 | 166 | -163 | 45 | 0.8 | -24 | -3.9 | -10 | -10 | -6.8 | 27 | -16 | 16 | -9.0 | 83 | 0.8 | -34 | -17 | |
| -9.0 | -18 | -53 | -52 | -47 | 157 | -11 | -29 | -47 | -40 | -90 | 9.9 | -9.5 | -3.6 | 4.6 | 45 | 50 | 64 | 31 | 12 | -16 | -110 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.